Vanguard Group Inc. Sells 172,782 Shares of USANA Health Sciences, Inc. $USNA

Key Points

• Vanguard Group Inc. has reduced its stake in USANA Health Sciences by 11.2%, selling 172,782 shares and now owning approximately 7.38% of the company.
• Other institutional investors, such as PNC Financial Services and Versant Capital Management, dramatically increased their holdings in USANA Health Sciences by over 300% in the first quarter.
• USANA Health Sciences recently reported earnings of $0.74 per share for the last quarter, surpassing expectations of $0.54 and setting its FY 2025 guidance at 2.350-3.000 EPS.

Vanguard Group Inc. cut its stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 11.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,373,908 shares of the company's stock after selling 172,782 shares during the period. Vanguard Group Inc. owned 7.38% of USANA Health Sciences worth $37,054,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. PNC Financial Services Group Inc. boosted its holdings in shares of USANA Health Sciences by 339.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock worth $27,000 after buying an additional 771 shares in the last quarter. Versant Capital Management Inc boosted its holdings in shares of USANA Health Sciences by 542.5% during the 1st quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after buying an additional 971 shares in the last quarter. Parallel Advisors LLC boosted its holdings in shares of USANA Health Sciences by 8,141.2% during the 1st quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock worth $38,000 after buying an additional 1,384 shares in the last quarter. US Bancorp DE boosted its holdings in shares of USANA Health Sciences by 13.1% during the 1st quarter. US Bancorp DE now owns 4,611 shares of the company's stock worth $124,000 after buying an additional 535 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of USANA Health Sciences by 635.5% during the 4th quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company's stock worth $182,000 after buying an additional 4,385 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors.

USANA Health Sciences Stock Up 1.7%

NYSE USNA traded up $0.54 on Monday, reaching $31.92. The company had a trading volume of 77,270 shares, compared to its average volume of 98,278. The stock has a market capitalization of $583.23 million, a P/E ratio of 17.74, a P/E/G ratio of 1.01 and a beta of 0.64. The company's fifty day moving average is $31.17 and its 200 day moving average is $29.56. USANA Health Sciences, Inc. has a 52-week low of $23.10 and a 52-week high of $41.83.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, beating analysts' consensus estimates of $0.54 by $0.20. The business had revenue of $235.85 million during the quarter, compared to analyst estimates of $225.20 million. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. USANA Health Sciences has set its FY 2025 guidance at 2.350-3.000 EPS. On average, research analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $36.00.

Insiders Place Their Bets

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,515 shares of the company's stock in a transaction on Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total value of $106,363.90. Following the completion of the transaction, the insider owned 9,260 shares in the company, valued at $280,207.60. This represents a 27.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gilbert A. Fuller sold 1,058 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $29.10, for a total value of $30,787.80. The disclosure for this sale can be found here. Insiders sold a total of 5,073 shares of company stock valued at $151,982 in the last 90 days. Corporate insiders own 0.63% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.